Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study
Article 2
The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients
Article 3
Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trial
Article 4
DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetic Patients Poorly Controlled with a Basal-Bolus Insulin Regimen
Article 5
Téleépied Study: A Single-Centre Trial in Diabetic Subjects Comparing Total Duration of Hospitalization Over a 1-Year Period Required for Complete Healing of a Foot Ulcer Using Telemedicine Management and a Referral Nurse Versus the Standard Care Pathway
Article 6
Diabeloop DBLG1 Closed-Loop
System Enables Patients With
Type 1 Diabetes to Significantly
Improve Their Glycemic Controlin
Real-Life Situations Without Serious Adverse Events: 6 Month Follow-up
Article 7
Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6–12 years: a randomised, controlled, cross-over, non inferiority trial
Article 8
Hybrid Closed-Loop Control with Ultrarapid Lispro Compared with Standard Insulin Aspart and Faster Insulin Aspart: An In silico Study
Article 9
Pathogenic variants in actionable MODY genes are associated with type 2 diabetes
